The Impact of Positron Emission Tomography with 18 F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial

Volume: 201, Issue: 2, Pages: 322 - 331
Published: Feb 1, 2019
Abstract
The prospective, multicenter LOCATE (F Fluciclovine [FACBC] PET/CT in Patients with Rising PSA after Initial Prostate Cancer Treatment) trial assessed the impact of positron emission tomography/computerized tomography with F-fluciclovine on treatment plans in patients with biochemical recurrence of prostate cancer after primary therapy with curative intent.Men who had undergone curative intent treatment of histologically confirmed prostate...
Paper Details
Title
The Impact of Positron Emission Tomography with 18 F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial
Published Date
Feb 1, 2019
Volume
201
Issue
2
Pages
322 - 331
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.